Neogenomics Inc
NASDAQ:NEO

Watchlist Manager
Neogenomics Inc Logo
Neogenomics Inc
NASDAQ:NEO
Watchlist
Price: 16.245 USD -0.64% Market Closed
Market Cap: 2.1B USD
Have any thoughts about
Neogenomics Inc?
Write Note

Neogenomics Inc
Stock-Based Compensation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Neogenomics Inc
Stock-Based Compensation Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Stock-Based Compensation Analysis
Latest Figures & CAGR of Competitors

Company Stock-Based Compensation CAGR 3Y CAGR 5Y CAGR 10Y
Neogenomics Inc
NASDAQ:NEO
Stock-Based Compensation
$32.1m
CAGR 3-Years
29%
CAGR 5-Years
27%
CAGR 10-Years
39%
Thermo Fisher Scientific Inc
NYSE:TMO
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Danaher Corp
NYSE:DHR
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mettler-Toledo International Inc
NYSE:MTD
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Agilent Technologies Inc
NYSE:A
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
IQVIA Holdings Inc
NYSE:IQV
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Neogenomics Inc's Stock-Based Compensation?
Stock-Based Compensation
32.1m USD

Based on the financial report for Sep 30, 2024, Neogenomics Inc's Stock-Based Compensation amounts to 32.1m USD.

What is Neogenomics Inc's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 10Y
39%

Over the last year, the Stock-Based Compensation growth was 44%. The average annual Stock-Based Compensation growth rates for Neogenomics Inc have been 29% over the past three years , 27% over the past five years , and 39% over the past ten years .

Back to Top